产品名称 | NebuSelect™ Recombinant Human TEM1/cd248, His-tag |
---|---|
目录号 | NBL-240730 |
别名 | TEM1/cd248; Endosialin; CD248; CD164L1; TEM1; CD164 sialomucin-like 1; CD164L1; CD248 molecule; MGC119479 |
外观 | see COA |
分子量 | Gln18-Leu687 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q9HCU0-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240730-100ug | 100ug | Inquire | Inquire | |
NBL-240730-1mg | 1mg | Inquire | Inquire | |
NBL-240730-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human TEM1/cd248, His-tag
Catalog#:
NBL-240730
Description:
NebuSelect™ Recombinant Human TEM1/cd248, His-tag(Cat#NBL-240730) is expressed in HEK293 with His tag at the C-Terminus.It contains Gln18-Leu687.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 72.7 kDa. Due to glycosylation, the protein migrates to 115-140 kDa based on Bis-Tris PAGE result.
Target Name:
TEM1/cd248; Endosialin; CD248; CD164L1; TEM1; CD164 sialomucin-like 1; CD164L1; CD248 molecule; MGC119479
Target Information:
Colorectal cancer (CRC) is one of the most common cancers worldwide usually diagnosed in the advanced stage. The serum concentration of tumor endothelial marker 1 (TEM1) was measured and correlated with clinicopathological features to evaluate whether TEM1 might serve as a biomarker for early CRC diagnosis, progression, and prognosis. TEM1 can act as a potential diagnostic, progression, and prognostic serum biomarker for patients with CRC; TEM1 might be a good supplement for commonly used markers CEA and Ca 19-9.
Amino Acid Sequence:
Gln18-Leu687
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.